Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised magnesium sulphate in stable severe asthma with persistent airflow limitation
NL-OMON29844Phase 4Not yet recruiting
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of magnesium sulfate in asthma (2 arms), sponsored by Medisch Centrum Leeuwarden. Primary endpoints: Percent change in FEV1 and Forced vital capacity. Planned start Oct 2006; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON29844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29844.